SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-17-000060
Filing Date
2017-10-30
Accepted
2017-10-30 17:15:07
Documents
85
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2017q310-q.htm 10-Q 1683154
2 EXHIBIT 10.1 a2017q310-q_exhibit101.htm EX-10.1 56241
3 EXHIBIT 10.2 a2017q310-q_exhibit102.htm EX-10.2 47745
4 EXHIBIT 31.1 a2017q310-q_exhibit311.htm EX-31.1 14551
5 EXHIBIT 31.2 a2017q310-q_exhibit312.htm EX-31.2 14385
6 EXHIBIT 32.1 a2017q310-q_exhibit321.htm EX-32.1 11907
  Complete submission text file 0000875320-17-000060.txt   9639044

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT vrtx-20170930.xml EX-101.INS 2313208
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20170930.xsd EX-101.SCH 68857
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20170930_cal.xml EX-101.CAL 102880
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20170930_def.xml EX-101.DEF 382132
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20170930_lab.xml EX-101.LAB 826834
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20170930_pre.xml EX-101.PRE 530496
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 171163257
SIC: 2834 Pharmaceutical Preparations